The interferon therapy has represented a breakthrough in the treatment of chronic hepatitis. In this article we analyzed the results of short- and long-term therapy of hepatitis C, particularly referred to different dosage regimens and side effects. We paid particular attention to patients non responders to interferon therapy, for whom we reported the results obtained with the association of interferon and ursodeoxycholic acid, and with steroidal treatment.